Member Info for Laura2022

Aquis

Cant believe you don't just filter him (Net)

Within 1 day I had filtered him back in Feb

Anyone who posts 99% on a stock they dont own is just strange

Hope everything works out here for genuine investors

Another new recent high

Thanks Cav

Added 12500 shares

Approaching 700,000

That's my top up

12.2mln

Just for the doom sayers

12.2mln in a few seconds

Now bidding 7.85p for 300k

Current spread 7 85-7.96p

Was all clear and in public domain

Member since Apr 2022

Posts: 17,858

Price: 1.05

No Opinion

USA lithium boom14 Jan 2026 14:20

Trump Administration wants Lithium,

Lithium is on the list of security minerals

Executive orders signed to get USA lithium secured using federal $25B

BHL is in Nevada and Arizona...... Join the dots.....

Lithium price on the rise

✅Lithium is also needed for military equipments...

I filtered this person 15mths ago

Talks utter nonsense on LSE

Laura2022

Member since Apr 2022

Posts: 17,856

Price: 1.75

No Opinion

RE: 100% up16 Jan 2026 12:55

Rick123

Good afternoon

I'm in at under 0.85p but holding very strong

Taken some profits after buying in January for 200% gains

What a coup

He currently serves as Head of Planning for AstraZeneca's c. $2 billion AXIAL transformation programme.

Mr Williams brings more than 30 years of experience advising and leading complex transformation programmes across life sciences and other regulated sectors. His background includes senior consulting roles with PwC and KPMG, alongside leadership positions delivering large-scale operational and digital transformation programmes for organisations including AstraZeneca, Victrex, BAE Systems and Co-operative Financial Services. He currently serves as Head of Planning for AstraZeneca's c. $2 billion AXIAL transformation programme.

10 green boxes since 4.30pm

What a life to lead folks

GENinCode has amassed significant investment over the past 15 years in its research and development of predictive and preventative technology to cardiovascular disease.

GENinCode has developed a proprietary online cloud-based system Sitab® to integrate patients clinical and genetic data and provide online reporting capabilities to health care practitioners.

The Core Products of GENinCode Include:

Cardio inCode® - Score and Check® - Coronary predictive/risk assessment.Thrombo inCode® - Hematology, Recurrent Pregnancy Loss and Oncology, Thrombosis (blood clots) predictive/risk assessment.Lipid inCode® - Familial Hypercholesterolemia Diagnosis and risk stratification.SudD inCode® - Hereditary Cardiomiopathies diagnosis, Risk assessment for sudden cardiac events.

Thanks KingH for that

At least try looking at thier website

I posted a link last week

And a delayed 2mln buy from Friday

For just over £7k

Real spread

4.26p to 4.4p